Rick Doblin: Overcome Trauma
Mayim Bialik's Breakdown
00:00
The FDA's Decision to Reject PTSD Therapy
After 12 months, two thirds no longer have PTSD. Of the one third that still has PTSD, almost all of them have had clinically significant reductions in PTSD symptoms. In order to satisfy the FDA that you have a statistically significant study, and we had a great safety profile, I'll just add that to it's 0.05, which means one in 20 chance that it's due to chance. And that's kind of the lowest level of safety that you can move forward with your research with.
Transcript
Play full episode
